Weekly Digest – March 2025 Weekly Digest – March 2025 27 Mar 2025: TIVDAK (Tisotumab vedotin) approved by Japan Ministry of Health, Labour and Welfare for the treatment of advanced or recurrent Cervical cancer that has progressed on or after […]
Contact:
info@ciscientists.com
+1-908-212-7484
Optimal Dose
For a subscription, please provide your email id